Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.
about
Hyperinsulinemic Hypoglycemia - The Molecular MechanismsLaparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure?Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanismsMetabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literatureGut-brain peptides in corticostriatal-limbic circuitry and alcohol use disordersPeripheral signals mediate the beneficial effects of gastric surgery in obesityEndoscopic Bariatric and Metabolic Therapies: Surgical Analogues and Mechanisms of Action.Gastrorenal Axis.Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic ProceduresRecent advances in clinical practice challenges and opportunities in the management of obesity.Age- and sex-specific effects on weight loss outcomes in a comparison of sleeve gastrectomy and Roux-en-Y gastric bypass: a retrospective cohort study.Role of gastrointestinal hormones in feeding behavior and obesity treatment.Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity.A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy.Jejunal administration of glucose enhances acyl ghrelin suppression in obese humansEffect on Nitrogen Balance, Thermogenesis, Body Composition, Satiety, and Circulating Branched Chain Amino Acid Levels up to One Year after Surgery: Protocol of a Randomized Controlled Trial on Dietary Protein During Surgical Weight Loss.Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency.GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?Prevention of Weight Regain Following Bariatric Surgery.What is the Mechanism Behind Weight Loss Maintenance with Gastric Bypass?Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis.Effects of Laparoscopic Sleeve Gastrectomy on Parathyroid Hormone, Vitamin D, Calcium, Phosphorus, and Albumin Levels.How to Choose the Best Metabolic Procedure?The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight.Three-Year Outcomes of Revisional Laparoscopic Gastric Bypass after Failed Laparoscopic Sleeve Gastrectomy: a Case-Matched Analysis.Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study.Fasting Circulating Glicentin Increases After Bariatric Surgery.Biological control of appetite: A daunting complexity.Gastrointestinal-Renal Axis: Role in the Regulation of Blood PressureMicronutrient Deficiencies After Bariatric Surgery: An Emphasis on Vitamins and Trace Minerals [Formula: see text].Endocrine Function after Bariatric Surgery.Gender Influence on Long-Term Weight Loss and Comorbidities After Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study With a 5-Year Follow-up.Potential Hormone Mechanisms of Bariatric Surgery.Jejunum-ileum circuit procedure improves glucose metabolism in diabetic rats independent of weight loss.Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores.Mechanisms of weight loss and improved metabolism following bariatric surgery.A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients.Relationship Between Tobacco Use and Weight Loss After Bariatric Surgery.Does Bariatric Surgery Improve Obesity Associated Comorbid Conditions.Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.
P2860
Q26749617-5C72E17F-4378-40D5-BAF0-D7645ADFBB12Q26778002-DF6074BE-D811-4F59-A032-DE06B3558CCEQ27000617-F9C7D3AE-EE2D-48C1-8C55-720FF2F26DA7Q27010589-64700E2B-0729-4032-9B6C-F7D7F4FDEC29Q27014840-681AE9A4-51F0-4420-9688-01A668F9CDA6Q28088425-EFA8A9AE-4011-4CF2-9515-E771BD0AB0FAQ30240029-53E385D3-ECC5-4781-B29C-96573AD85E89Q30277035-33AB5833-E4AE-4019-9120-36439CE2C459Q33811372-0707FA68-F934-468D-BB97-7F3996E379D4Q34219768-D1CA3D5E-B058-4240-A24D-797BF31790D8Q35718378-72EA5C3F-5E96-4078-8202-897D0677147BQ35766237-04D94224-4C52-43EA-8013-F0F1FD7242A7Q36300539-BFBEAB9A-459C-4C7D-A7B8-A21083BAE53AQ36360575-C8F63435-AEBF-4540-AABF-AA94F8403006Q37139405-F1AF0E1E-E990-4F45-8A0B-73C66B02D820Q37497243-291B4949-AE40-40F3-8F21-FA7044476636Q38270358-C5CBA5DB-3C61-4973-894B-57C261E0472BQ38307449-785C420F-DDA5-46F4-88D5-B298EB3D7196Q38655854-33E43D0B-E919-47B1-BBA3-F99B64F9D448Q38655873-17104165-A769-4EE3-BD93-BFA92739D701Q38667659-737D7743-1458-44D1-8055-35FD0F881E46Q38751491-B8D4A509-672B-499E-B84E-F81DA573B893Q38845417-1BDA7AA6-B759-4691-9E8B-F7CF691892B6Q38850561-45500989-F2DF-450B-84C9-40B08C27F14CQ38925733-F1FB7566-473B-4547-AEBF-3924F99FE37EQ39076089-6F78AE12-0021-4850-9832-156E6680CC2FQ39093238-F6639F3C-1462-4FF2-BF2A-7B4641807503Q39147573-B944226E-DE07-4218-9B29-6E6EBE327964Q39164330-2F1F85E5-EBC6-494C-8780-B89577588AB6Q39369814-5EF0BAE6-486B-4A98-9C36-05C1D82223ADQ39390970-318A5118-13EB-45E0-AAEC-3371266F08D9Q40879959-E4C2176B-4EDE-4210-B1E7-9FCB9405B426Q41625381-1269BB41-40D2-4B23-9DCE-368652C81334Q46263677-F18EC8E9-517B-4FCD-930C-73EB9744A8BEQ46364544-255AFCF4-CCAA-4370-BE7C-3EDA1DF66A80Q47190446-AF30F377-59EF-48BB-B9C5-87E45C5C5AE3Q47319565-36C72119-447C-4597-9302-367B91642FF2Q47336977-F626C287-5007-4AD1-AB2B-B96EFB778A18Q47559232-4D26CFB2-871C-498C-882A-67D0F5548D38Q47800514-42751C0F-56CE-4950-9F44-540FF5DF5594
P2860
Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential effects of laparo ...... levels in non-diabetic humans.
@en
Differential effects of laparo ...... levels in non-diabetic humans.
@nl
type
label
Differential effects of laparo ...... levels in non-diabetic humans.
@en
Differential effects of laparo ...... levels in non-diabetic humans.
@nl
prefLabel
Differential effects of laparo ...... levels in non-diabetic humans.
@en
Differential effects of laparo ...... levels in non-diabetic humans.
@nl
P2093
P2860
P50
P1433
P1476
Differential effects of laparo ...... levels in non-diabetic humans.
@en
P2093
Ahmed Yousseif
Alberic G Fiennes
Andrew D Jenkinson
Efthimia Karra
Julian Emmanuel
Majid Hashemi
Marco Adamo
Mohamed Elkalaawy
Queensta Millet
P2860
P2888
P304
P356
10.1007/S11695-013-1066-0
P577
2014-02-01T00:00:00Z